Post by Angel Invest

We’re excited to announce our investment in dehaze, as part of the company’s €3.2 million Seed round, led by DN Capital, and YZR Capital, alongside others. dehaze is building an AI platform for chronic disease detection, addressing one of the largest cost drivers in global healthcare. By analyzing patient data at scale, the platform helps identify elevated risks earlier, improving outcomes while reducing costs for payers and providers. 📊📉 “dehaze is tackling one of healthcare’s biggest inefficiencies with a scalable AI-first approach. We’re excited to back a team combining strong execution with clear customer value.” — Karl Joseph Seilern Built in Munich 🇩🇪 and operating globally from day one, dehaze is exactly the kind of ambitious company we’re proud to support. Congratulations to Marius Klages and the entire team! PR: https://lnkd.in/dPuqfjMa